Logo

American Heart Association

  13
  0


Final ID: Su2048

A 10 Year Report on Fontan Candidacy

Abstract Body (Do not enter title and authors here): Background:
As patients progress through the single ventricle palliation, changing hemodynamics and non-cardiac conditions can prevent completion of Fontan. We sought to determine the incidence of completion of Fontan at our institution and to investigate the reasons for non-Fontan candidacy.
Methods:
Institutional database was queried to identify patients who underwent single ventricle palliation from 2010 to 2020. Patients who underwent stage 2 palliation were included for analysis. The primary outcome of interest was reason for non-Fontan candidacy or reason for delayed Fontan.
Results:
526 patients who reached stage 2 single ventricle palliation were analyzed. 378 (71.9%) underwent Fontan procedure or were referred for Fontan before the age of 4-years-old at our center at the time of the study (Figure 1). 19 patients died prior to the typical age of Fontan and 38 were lost to follow up. Of the remaining 91 patients, 21 (23.1%) had a 1.5 or 2 ventricle repair, 12 (13.2%) had a Fontan at another center, and 29 (32%) had a late Fontan. Most patients with late Fontan were due to provider practice variation (22), whereas there were only 3 patients with medical conditions delaying pre-Fontan testing, and 4 patients had a Kawashima. Only 3 patients out of the 12 who had Fontan at another center were for second opinions, whereas the remainder either moved or had surgery at another center due to family preference. Reasons for non-Fontan candidacy were divided into cardiac and respiratory sources. Cardiac reasons included severely depressed ventricular function (12), diastolic dysfunction (2), atrioventricular valve stenosis or regurgitation (7), and pulmonary vein stenosis (3). Respiratory conditions leading to non-Fontan candidacy included severe OSA (1), pulmonary arterial malformation (1), and pneumonectomy (2). There are 17 patients in the non-candidacy group who had a heart transplant or were listed for transplant at the time of the study. No patient in our study was deemed not a candidate for Fontan after stage 2 palliation for developmental delay or syndrome.
Discussion:
This study demonstrates that the reasons for non-Fontan candidacy after completion of stage 2 palliation are broadly due to hemodynamic and respiratory condition, with many patients who are not candidates developing severe ventricular dysfunction after stage 2. There is a subset of patients who either move, are lost to follow up, or are delayed due to provider practice variation.
  • Adamson, Marissa  ( Emory University , Atlanta , Georgia , United States )
  • John, Mohan  ( Emory University , Atlanta , Georgia , United States )
  • Nayi, Pranay  ( Emory University , Atlanta , Georgia , United States )
  • Deshpande, Shriprasad  ( Children's National Health System , Washington , District of Columbia , United States )
  • Ferguson, Matthew  ( Emory University , Atlanta , Georgia , United States )
  • Maher, Kevin  ( Emory University , Atlanta , Georgia , United States )
  • Chai, Paul  ( Emory University , Atlanta , Georgia , United States )
  • Beshish, Asaad  ( Emory University , Atlanta , Georgia , United States )
  • Author Disclosures:
    Marissa Adamson: DO NOT have relevant financial relationships | Mohan John: DO NOT have relevant financial relationships | Pranay Nayi: No Answer | Shriprasad Deshpande: DO have relevant financial relationships ; Speaker:Natera Inc:Past (completed) | Matthew Ferguson: No Answer | Kevin Maher: No Answer | Paul Chai: DO NOT have relevant financial relationships | Asaad Beshish: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Acquired and Congenital Heart Defects and Surgical Interventions

Sunday, 11/17/2024 , 03:15PM - 04:15PM

Abstract Poster Session

More abstracts on this topic:
Computational Fluid Dynamics is Key Predictors of Adverse Events in Single Ventricle Patients After the Fontan

Wei Zhenglun, Salargarna Fatemeh, Murawsky Jessica, Si Biao, Frechette Joshua, Carter Allen, Zou Jian, Yoganathan Ajit, Fogel Mark

Fontan-Associated Liver Disease On A Chip

Rezapourdamanab Sarah, Dasi Lakshmi, Romero Rene, Bauser Heaton Holly, Serpooshan Vahid, Singh Yamini, Norton Sophia, Hwang Boeun, Jin Linqi, Salar Amoli Mehdi, Karnik Shweta, Avazmohammadi Reza, Neelakantan Sunder

More abstracts from these authors:
Early total cell-free DNA, but not donor fraction, predicts late events in heart transplantation

Zangwill Steven, Deshpande Shriprasad, Richmond Marc, Zhang Liyun, Simpson Pippa, Dasgupta Mahua, Tomita-mitchell Aoy, Mitchell Michael

Impact of Angiotensin Receptor Neprilysin Inhibitor on Chronic Heart Failure with Reduced Ejection Fraction in Adult Congenital Heart Disease Patients: A Systematic Review and Meta-analysis

Das Bibhuti, Deshpande Shriprasad, Nikolaidis Lazaros, Hernandez-montfort Jaime, Niu Jianli

You have to be authorized to contact abstract author. Please, Login
Not Available